Maternal factor v Leiden and adverse pregnancy outcome: Deciding whether or not to test

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 25, Issue 7, 2012, Pages 889-894

  Dudding, Tracy E ^a   Attia, John ^a  

^a UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

Fetal growth restriction; Intrauterine fetal death; Pre eclampsia; Recurrent miscarriage; Thrombophilia

Indexed keywords

ACETYLSALICYLIC ACID; BLOOD CLOTTING FACTOR 5 LEIDEN; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN; PLACEBO;

ANTICOAGULANT THERAPY; COMBINATION CHEMOTHERAPY; DISEASE ASSOCIATION; DISEASE SEVERITY; FETUS WASTAGE; FIRST TRIMESTER PREGNANCY; GENETIC SCREENING; HETEROZYGOTE; HIGH RISK POPULATION; HUMAN; INTRAUTERINE GROWTH RETARDATION; MONOTHERAPY; PREECLAMPSIA; PREGNANCY OUTCOME; PRIORITY JOURNAL; RECURRENCE RISK; REVIEW; SECOND TRIMESTER PREGNANCY; SPONTANEOUS ABORTION; STILLBIRTH; THIRD TRIMESTER PREGNANCY; THROMBOPHILIA;

FACTOR V; FEMALE; GENETIC TESTING; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; THROMBOPHILIA;

EID: 84862849958     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2011.608815     Document Type: Review

References (54)

1. De Stefano V, Chiusolo P, Paciaroni K, Leone G. Epidemiology of factor V1 Leiden: Clinical implications. Semin Thromb Hemost 1998;24:367-379. (Pubitemid 28440714)
2. Pabinger I. Thrombophilia and its impact on pregnancy. Thromb Res 2009;123 Suppl 3:S16-S21.
3. Rey E, Kahn SR, David M, Shrier I. Thrombophilic disorders and fetal loss: A meta-analysis. Lancet 2003;361:901-908. (Pubitemid 36335814)
4. Dudding TE, Attia J. The association between adverse pregnancy outcomes and maternal factor V Leiden genotype: A meta-analysis. Thromb Haemost 2004;91:700-711. (Pubitemid 38477450)
5. Kovalevsky G, Gracia CR, Berlin JA, Sammel MD, Barnhart KT. Evaluation of the association between hereditary thrombophilias and recurrent pregnancy loss: A meta-analysis. Arch Intern Med 2004;164:558-563. (Pubitemid 38314453)
6. Robertson L, Wu O, Langhorne P, Twaddle S, Clark P, Lowe GD, Walker ID, et al.; Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study. Thrombophilia in pregnancy: A systematic review. Br J Haematol 2006;132:171-196.
7. Rodger MA, Betancourt MT, Clark P, Lindqvist PG, Dizon-Townson D, Said J, Seligsohn U, et al. The association of factor V Leiden and prothrombin gene mutation and placenta-mediated pregnancy complications: A systematic review and meta-analysis of prospective cohort studies. PLoS Med 2010;7:e1000292.
8. Wang X, Chen C, Wang L, Chen D, Guang W, French J. Conception, early pregnancy loss, and time to clinical pregnancy: A populationbased prospective study. Fertil Steril 2003;79:577-584. (Pubitemid 36293455)
9. Kosmas IP, Tatsioni A, Ioannidis JP. Association of Leiden mutation in factor V gene with hypertension in pregnancy and pre-eclampsia: A meta-analysis. J Hypertens 2003;21:1221-1228.
10. Lin J, August P. Genetic thrombophilias and preeclampsia: A metaanalysis. Obstet Gynecol 2005;105:182-192.
11. Dudding T, Heron J, Thakkinstian A, Nurk E, Golding J, Pembrey M, Ring SM, et al. Factor V Leiden is associated with pre-eclampsia but not with fetal growth restriction: A genetic association study and metaanalysis. J Thromb Haemost 2008;6:1869-1875.
12. Howley HE, Walker M, Rodger MA. A systematic review of the association between factor V Leiden or prothrombin gene variant and intrauterine growth restriction. Am J Obstet Gynecol 2005;192:694-708. (Pubitemid 40311258)
13. Facco F, You W, Grobman W. Genetic thrombophilias and intrauterine growth restriction: A meta-analysis. Obstet Gynecol 2009;113:1206-1216.
14. Lindqvist PG, Svensson PJ, Marsa K, Grennert L, Luterkort M, Dahlbk B. Activated protein C resistance (FV:Q506) and pregnancy. Thromb Haemost 1999;81:532-537. (Pubitemid 29178936)
15. Grandone E, Colaizzo D, Tiscia G, Vergura P, Cappucci F, Greco L, Margaglione M, Martinelli P; Prenacel Study Group. Impact of common thrombophilias and JAK2 V617F on pregnancy outcomes in unselected Italian women. J Thromb Haemost 2011;9:496-501.
16. Sedano-Balb S, Lyons M, Cleary B, Murray M, Gaffney G, Maher M. APCR, factor V gene known and novel SNPs and adverse pregnancy outcomes in an Irish cohort of pregnant women. BMC regnancy Childbirth 2010;10:11.
17. Said JM, Higgins JR, Moses EK, Walker SP, Borg AJ, Monagle PT, Brennecke SP. Inherited thrombophilia polymorphisms and pregnancy outcomes in nulliparous women. Obstet Gynecol 2010;115:5-13.
18. Kahn SR, Platt R, McNamara H, Rozen R, Chen MF, Genest J Jr, Goulet L, et al. Inherited thrombophilia and preeclampsia within a multicenter cohort: The Montreal Preeclampsia Study. Am J Obstet Gynecol 2009;200:151.e1-9; discussion e1.
19. Clark P, Wu O. ABO(H) blood groups and pre-eclampsia. A systematic review and meta-analysis. Thromb Haemost 2008;100:469-474.
20. Lindqvist PG, Svensson P, Dahlbk B. Activated protein C resistance ? in the absence of factor V Leiden ? and pregnancy. J Thromb Haemost 2006;4:361-366.
21. Kocher O, Cirovic C, Malynn E, Rowland CM, Bare LA, Young BA, Henslee JG, et al. Obstetric complications in patients with hereditary thrombophilia identified using the LCx microparticle enzyme immunoassay: A controlled study of 5,000 patients. Am J Clin Pathol 2007;127:68-75. (Pubitemid 46797020)
22. Dizon-Townson D, Miller C, Sibai B, Spong CY, Thom E, Wendel D Jr, Wenstrom K, et al.; National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. The relationship of the factor V Leiden mutation and pregnancy outcomes for mother and fetus. Obstet Gynecol 2005;106:517-524. (Pubitemid 41208783)
23. Nurk E, Tell GS, Refsum H, Ueland PM, Vollset SE. Factor V Leiden, pregnancy complications and adverse outcomes: The Hordaland Homocysteine Study. QJM 2006;99:289-298.
24. Ganzevoort W, Rep A, De Vries JI, Bonsel GJ, Wolf H. Relationship between thrombophilic disorders and type of severe earlyonset hypertensive disorder of pregnancy. Hypertens Pregnancy 2007;26:433-45. (Pubitemid 350232905)
25. Murphy RP, Donoghue C, Nallen RJ, D'Mello M, Regan C, Whitehead AS, Fitzgerald DJ. Prospective evaluation of the risk conferred by factor V Leiden and thermolabile methylenetetrahydrofolate reductase polymorphisms in pregnancy. Arterioscler Thromb Vasc Biol 2000;20:266-270. (Pubitemid 30048374)
26. Lund M, Nielsen HS, Hviid TV, Steffensen R, Nyboe Andersen A, Christiansen OB. Hereditary thrombophilia and recurrent pregnancy loss: A retrospective cohort study of pregnancy outcome and obstetric complications. Hum Reprod 2010;25:2978-2984.
27. Hiltunen LM, Laivuori H, Rautanen A, Kaaja R, Kere J, Krusius T, Paunio M, Rasi V. Factor V Leiden as risk factor for unexplained stillbirth -a population-based nested case-control study. Thromb Res 2010;125:505-510.
28. Simchen MJ, Ofir K, Moran O, Kedem A, Sivan E, Schiff E. Thrombophilic risk factors for placental stillbirth. Eur J Obstet Gynecol Reprod Biol 2010;153:160-164.
29. Foka ZJ, Lambropoulos AF, Saravelos H, Karas GB, Karavida A, Agorastos T, Zournatzi V, et al. Factor V Leiden and prothrombin G20210A mutations, but not methylenetetrahydrofolate reductase C677T, are associated with recurrent miscarriages. Hum Reprod 2000;15:458-462. (Pubitemid 30076732)
30. Herñdez-Dz S, Toh S, Cnattingius S. Risk of pre-eclampsia in first and subsequent pregnancies: Prospective cohort study. BMJ 2009;338:b2255.
31. Lykke JA, Paidas MJ, Langhoff-Roos J. Recurring complications in second pregnancy. Obstet Gynecol 2009;113:1217-1224.
32. Mostello D, Kallogjeri D, Tungsiripat R, Leet T. Recurrence of preeclampsia: Effects of gestational age at delivery of the first pregnancy, body mass index, paternity, and interval between births. Am J Obstet Gynecol 2008;199:55.e1-55.e7.
33. Brown MA, Mackenzie C, Dunsmuir W, Roberts L, Ikin K, Matthews J, Mangos G, Davis G. Can we predict recurrence of pre-eclampsia or gestational hypertension? BJOG 2007;114:984-993. (Pubitemid 47052742)
34. Trogstad L, Skrondal A, Stoltenberg C, Magnus P, Nesheim BI, Eskild A. Recurrence risk of preeclampsia in twin and singleton pregnancies. Am J Med Genet A 2004;126A:41-45. (Pubitemid 38436471)
35. Lie RT, Rasmussen S, Brunborg H, Gjessing HK, Lie-Nielsen E, Irgens LM. Fetal and maternal contributions to risk of pre-eclampsia: Population based study. BMJ 1998;316:1343-1347. (Pubitemid 28195872)
36. Makkonen N, Heinonen S, Kirkinen P. Obstetric prognosis in second pregnancy after preeclampsia in first pregnancy. Hypertens Pregnancy 2000;19:173-181. (Pubitemid 30436484)
37. Sibai BM, Mercer B, Sarinoglu C. Severe preeclampsia in the second trimester: Recurrence risk and long-term prognosis. Am J Obstet Gynecol 1991;165:1408-1412.
38. McDonald SD, Best C, Lam K. The recurrence risk of severe de novo pre-eclampsia in singleton pregnancies: A population-based cohort. BJOG 2009;116:1578-1584.
39. Bhattacharya S, Townend J, Bhattacharya S. Recurrent miscarriage: Are three miscarriages one too many? Analysis of a Scottish populationbased database of 151,021 pregnancies. Eur J Obstet Gynecol Reprod Biol 2010;150:24-27.
40. Brigham SA, Conlon C, Farquharson RG. A longitudinal study of pregnancy outcome following idiopathic recurrent miscarriage. Hum Reprod 1999;14:2868-2871. (Pubitemid 29520709)
41. Clifford K, Rai R, Regan L. Future pregnancy outcome in unexplained recurrent first trimester miscarriage. Hum Reprod 1997;12:387-389. (Pubitemid 27129408)
42. Bhattacharya S, Prescott GJ, Black M, Shetty A. Recurrence risk of stillbirth in a second pregnancy. BJOG 2010;117:1243-1247.
43. Sharma PP, Salihu HM, Kirby RS. Stillbirth recurrence in a population of relatively low-risk mothers. Paediatr Perinat Epidemiol 2007;21 Suppl 1:24-30. (Pubitemid 46934406)
44. Brenner B, Hoffman R, Blumenfeld Z, Weiner Z, Younis JS. Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin. Thromb Haemost 2000;83:693-697. (Pubitemid 30248516)
45. Brenner B, Hoffman R, Carp H, Dulitsky M, Younis J; Live-Enox Investigators. Efficacy and safety of two doses of enoxaparin in women with thrombophilia and recurrent pregnancy loss: The Live-Enox study. J Thromb Haemost 2005;3:227-229. (Pubitemid 41623606)
46. Kupferminc MJ, Fait G, Many A, Lessing JB, Yair D, Bar-Am A, Eldor A. Low-molecular-weight heparin for the prevention of obstetric complications in women with thrombophilias. Hypertens Pregnancy 2001;20:35-44. (Pubitemid 32672926)
47. Gris JC, Mercier E, Qu I, Lavigne-Lissalde G, Cochery-Nouvellon E, Hoffet M, Ripart-Neveu S, et al. Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder. Blood 2004;103:3695-3699. (Pubitemid 38596284)
48. Carp H, Dolitzky M, Inbal A. Thromboprophylaxis improves the live birth rate in women with consecutive recurrent miscarriages and hereditary thrombophilia. J Thromb Haemost 2003;1:433-438.
49. Sanson BJ, Lensing AW, Prins MH, Ginsberg JS, Barkagan ZS, Lavenne-Pardonge E, Brenner B, et al. Safety of low-molecularweight heparin in pregnancy: A systematic review. Thromb Haemost 1999;81:668-672. (Pubitemid 29216546)
50. Kupferminc MJ, Rimon E, Many A, Sharon M, Lessing JB, Gamzu R. Low molecular weight heparin treatment during subsequent pregnancies of women with inherited thrombophilia and previous severe pregnancy complications. J Matern Fetal Neonatal Med 2011;24:1042-1045.
51. Clark P, Walker ID, Langhorne P, Crichton L, Thomson A, Greaves M, Whyte S, Greer IA; Scottish Pregnancy Intervention Study (SPIN) collaborators. SPIN (Scottish Pregnancy Intervention) study: A multicenter, randomized controlled trial of low-molecular-weight heparin and low-dose aspirin in women with recurrent miscarriage. Blood 2010;115:4162-4167.
52. Kaandorp SP, Goddijn M, van der Post JA, Hutten BA, Verhoeve HR, Hamuly K, Mol BW, et al. Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. N Engl J Med 2010;362:1586-1596.
53. Sarig G, Vidergor G, Brenner B. Assessment and management of high-risk pregnancies in women with thrombophilia. Blood Rev 2009;23:143-147.
54. Kist WJ, Janssen NG, Kalk JJ, Hague WM, Dekker GA, de Vries JI. Thrombophilias and adverse pregnancy outcome -A confounded problem! Thromb Haemost 2008;99:77-85.